Report Company Directory
- ValuEngine Rating and Forecast Report for AKTX by ValuEngine Inc
- ValuEngine Rating and Forecast Report for AKTX by ValuEngine Inc
- ValuEngine Rating and Forecast Report for AKTX by ValuEngine Inc
- ValuEngine Rating and Forecast Report for AKTX by ValuEngine Inc
- AKARI THERAPEUTICS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Akari Therapeutics, Plc – (AKTX) by BusinessWire
- AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm by BusinessWire
- AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm by BusinessWire
- AKARI THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Akari Therapeutics, Plc – (AKTX) by BusinessWire
- Akari Therapeutics Announces Resignation of CEO by BusinessWire
- IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Akari Therapeutics, Plc and Advises Investors With Losses to Contact the Firm by BusinessWire